Xie Yongyan, Qin Yinfang, Wang Jingjing, Xu Ziwei, Chen Liping, Kuang Yunxia, Yang Ruwei, Huang Liping
School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China.
College of Traditional Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, China.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan 29. doi: 10.1007/s00210-025-03828-2.
Microglia-mediated neuroinflammation plays a crucial role in Alzheimer's disease (AD). Tinosinenside A (Tis A) is a novel sesquiterpene glycoside isolated from the dried rattan stem of Tinospora sinensis (Lour.) Merr. Tis A exhibited anti-inflammatory and neuroprotective activities in vitro. However, the mechanism underlying the inhibition of neuroinflammation and protection of nerve cells remains obscure. This study used lipopolysaccharide (LPS)-induced inflammatory response in BV2 cells to simulate a neuroinflammatory model and used Aβ-induced HT22 cells to establish an AD cell model, aiming to investigate the efficacy and mechanism of Tis A through anti-neuroinflammation to protect nerve cells. Tis A had no effect on the proliferation of BV2 and HT22 cells at the tested concentrations. The time- and dose-dependent effects of Tis A on the LPS-induced inflammatory response of BV2 cells demonstrated that the best anti-inflammatory efficacy appeared after 12 h of pretreatment. Tis A inhibited the gene levels of TNF-α, IL-6, IL-1β, iNOS, and IL-10 while enhancing the gene levels of IL-4 and TGF-β. Additionally, Tis A reduced the gene expression levels of CD16 and CD32 and increased the CD36 and CD206 gene expression levels. It also downregulated the protein expression of Iba-1 and iNOS while upregulating CD206. Tis A obviously inhibited NLRP3 gene and protein expression in LPS-stimulated BV2 cells. The inhibitory effect of Tis A on NLRP3 was counteracted by the NLRP3 activator nigericin and overexpression plasmid GV358. Tis A inhibits NLRP3 protein expression to reduce the assembly of NLRP3/ASC/Caspase-1 inflammasome, then regulates the TLR4/NF-κB/NLRP3 signaling pathway. It regulates microglia activation and M1/M2 phenotypic polarization, then inhibits the production of inflammatory factors, and reduces the apoptosis rate of HT22 cells under inflammatory conditions, improving the survival rate of nerve cells to protect neurons.
小胶质细胞介导的神经炎症在阿尔茨海默病(AD)中起关键作用。青藤碱A(Tis A)是从中华青牛胆干燥藤茎中分离得到的一种新型倍半萜糖苷。Tis A在体外表现出抗炎和神经保护活性。然而,其抑制神经炎症和保护神经细胞的潜在机制仍不清楚。本研究利用脂多糖(LPS)诱导BV2细胞的炎症反应来模拟神经炎症模型,并利用Aβ诱导HT22细胞建立AD细胞模型,旨在研究Tis A通过抗神经炎症保护神经细胞的疗效和机制。在测试浓度下,Tis A对BV2和HT22细胞的增殖没有影响。Tis A对LPS诱导的BV2细胞炎症反应的时间和剂量依赖性作用表明,预处理12小时后抗炎效果最佳。Tis A抑制TNF-α、IL-6、IL-1β、iNOS和IL-10的基因水平,同时提高IL-4和TGF-β的基因水平。此外,Tis A降低CD16和CD32的基因表达水平,增加CD36和CD206的基因表达水平。它还下调Iba-1和iNOS的蛋白表达,同时上调CD206。Tis A明显抑制LPS刺激的BV2细胞中NLRP3基因和蛋白表达。Tis A对NLRP3的抑制作用被NLRP3激活剂尼日利亚菌素和过表达质粒GV358抵消。Tis A抑制NLRP3蛋白表达以减少NLRP3/ASC/Caspase-1炎性小体的组装,进而调节TLR4/NF-κB/NLRP3信号通路。它调节小胶质细胞活化和M1/M2表型极化,进而抑制炎性因子的产生,并降低炎性条件下HT22细胞的凋亡率,提高神经细胞的存活率以保护神经元。